pharmabiz.com Unethical practice of dispensing cheap substitutes of low molecular weight heparin to patients, suffering from cardiac arrest, is found to be flourishing in several parts of India. These products are being sold at four times the actual cost by evading ...
Monthly Prescribing Reference Hospira has announced a voluntary nationwide user-level recall of one lot of Heparin Sodium, 1,000 USP Heparin Units/500mL (2 USP Hepa...
Medscape WASHINGTON, DC — US cardiologists attending TCT 2014 finally got a first-hand look at the Chinese BRIGHT trial, heralded as the first randomized trial to compar...
AAP News (subscription) One lot of heparin sodium injection is being recalled due to the presence of a foreign particle in one unit. Hospira Inc., of Lake Forest, Ill....
Regulatory Focus A Chinese-based manufacturer of heparin products has been sent a Warning Letter by the US Food and Drug Administration (FDA) after regulators accused the company of preventing FDA inspectors from accessing the facility earlier this year, and possibly ...
